ReviewFrontiers in cell and developmental biology2026
Human stem cell-based embryo models: from self-organization to recapitulating development.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human stem cell-based embryo models (hereafter referred to as embryo models) are a rapidly evolving field at the intersection of developmental biology and bioengineering. In this review, we examine design principles, material systems, and engineering approaches that enable the construction of models arising from pluripotent stem cells. We consider how three-dimensional environments, synthetic hydrogels, and spatiotemporal modulation of morphogenetic signals guide self-organization. Together, these factors enable the recapitulation of stages from blastocyst formation to early organogenesis. We then discuss opportunities of these engineered systems in disease modeling and developmental toxicity screening. We also address the scaling issues and biomanufacturing limitations that must be overcome to enable standardized, high-fidelity production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.